Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer.

Grandis JR, Skorupski KA, Cheng N, Cui Z, Li H, Woerner LC, Gencel-Augusto J, Zeng Y, Shiah JV, Bhola NE, Sen M, Blum K, Kim MO, York D, Rebhun RB, Chang H, Murad NF, Olshen AB, Sparger EE, Johnson DE